Quetiapine Fumarate
Product Images NDC 68071-3463

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 68071-3463). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3463 6)

Quetiapine 50mg tablets packaging label from NuCare Pharmaceuticals, Inc. The label specifies the product as Quetiapine fumarate 50mg, with a package count of 60 tablets in extended-release (E-R) form. It includes the NDC number 68071-3463-6, dosage instructions, and warnings to keep out of reach of children and store at controlled temperature 68-77°F. Additional lot and expiration date information are provided.*

FDA Label Image

Figure 1 Kaplan-meier Curves Of Time To Schizophrenic Relapse Study 3.jpg (Quetiapine Figure 1)

A Kaplan-Meier plot showing the proportion of patients with relapse over time (months). The graph compares two groups labeled PLA and QTP XR with relapse proportions on the vertical axis and time in months on the horizontal axis.*

FDA Label Image

Figure 2 Kaplan-maier Curves Of Time To Recurrence Of A Mood Event.jpg (Quetiapine Figure 2)

A line graph displaying the proportion of patients with relapse over time in weeks. Two groups are compared: QTP+ LI/VAL and PLA+ LI/VAL. The y-axis represents the percentage of patients with relapse, and the x-axis represents time in weeks, showing the progression of relapse rates for both groups over approximately 100 weeks.*

FDA Label Image

Figure 3 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 19).jpg (Quetiapine Figure 3)

A line graph depicting the proportion of patients with relapse (%) over time in weeks. It compares two groups labeled as QTP+LIVAL (dashed line) and PLA+LIVAL (solid line), showing relapse rates increasing over approximately 100 weeks, with the PLA+LIVAL group exhibiting a higher relapse proportion throughout the period.*

FDA Label Image

Structural Formula (Quetiapine Structure)

Chemical structure of quetiapine fumarate, illustrating the two quetiapine molecules and the fumarate ion as represented in the molecular formula.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.